Comparative analysis of mouse-induced pluripotent stem cells and mesenchymal stem cells during osteogenic differentiation in vitro

Stem Cells and Development

Volumn 23, Issue 18, 2014, Pages 2156-2169

  Egusa, Hiroshi ^a,b   Kayashima, Hiroki ^a   Miura, Jiro ^a   Uraguchi, Shinya ^a   Wang, Fangfang ^a   Okawa, Hiroko ^a   Sasaki, Jun Ichi ^a   Saeki, Makio ^c   Matsumoto, Takuya ^d   Yatani, Hirofumi ^a  

^a OSAKA UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^d OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTEGRIN; AMELOBLASTIN; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 5; BONE MORPHOGENETIC PROTEIN 6; BONE SIALOPROTEIN; CALCIUM PHOSPHATE; CATHEPSIN K; CD36 ANTIGEN; COLONY STIMULATING FACTOR; FETUIN A; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 3; GELATINASE A; GELATINASE B; GROWTH DIFFERENTIATION FACTOR 10; HYDROXYAPATITE; INTERCELLULAR ADHESION MOLECULE 1; MATRIX METALLOPROTEINASE; OSTEOCALCIN; OSTEOGENIN; SCLEROSTIN; STROMELYSIN 2; TRANSCRIPTION FACTOR DLX5; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; BIOLOGICAL MARKER;

ADULT; ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; BONE MINERALIZATION; CELL AGGREGATION; CELL DIFFERENTIATION; CELL STRUCTURE; CELL SURFACE; CELL TYPE; CELL ULTRASTRUCTURE; COLLAGEN FIBRIL; COMPARATIVE STUDY; CONTROLLED STUDY; CRYSTAL STRUCTURE; CYTOPLASM; DOWN REGULATION; EXTRACELLULAR MATRIX; GENE EXPRESSION; IN VITRO STUDY; MALE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OSTEOBLAST; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY; UPREGULATION; ANIMAL; C57BL MOUSE; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; ULTRASTRUCTURE;

ANIMALS; BIOLOGICAL MARKERS; CALCIFICATION, PHYSIOLOGIC; CELL DIFFERENTIATION; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; INDUCED PLURIPOTENT STEM CELLS; MALE; MESENCHYMAL STROMAL CELLS; MICE, INBRED C57BL; OSTEOGENESIS;

EID: 84906996507     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2013.0344     Document Type: Article

References (76)

1. Greenwald AS, SD Boden, VM Goldberg, Y Khan, CT Laurencin and RN Rosier. (2001). Bone-graft substitutes: facts, fictions, and applications. J Bone Joint Surg Am 83-A Suppl 2 Pt 2:98-103.
2. De Long WG, Jr., TA Einhorn, K Koval, M McKee, W Smith, R Sanders and T Watson. (2007). Bone grafts and bone graft substitutes in orthopaedic trauma surgery. A critical analysis. J Bone Joint Surg Am 89:649-658.
3. Egusa H. (2012). iPS cells in dentistry. Clin Calcium 22:67-73.
4. Egusa H, W Sonoyama, M Nishimura, I Atsuta and K Akiyama. (2012). Stem cells in dentistry-Part II: clinical applications. J Prosthodont Res 56:229-248.
5. Meijer GJ, JD de Bruijn, R Koole and CA van Blitterswijk. (2007). Cell-based bone tissue engineering. PLoS Med 4:e9.
6. Takahashi K and S Yamanaka. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676.
7. Takahashi K, K Tanabe, M Ohnuki, M Narita, T Ichisaka, K Tomoda and S Yamanaka. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861-872.
8. Egusa H, W Sonoyama, M Nishimura, I Atsuta and K Akiyama. (2012). Stem cells in dentistry-part I: stem cell sources. J Prosthodont Res 56:151-165.
9. Vater C, P Kasten and M Stiehler. (2011). Culture media for the differentiation of mesenchymal stromal cells. Acta Biomater 7:463-477.
10. Tashiro K, M Inamura, K Kawabata, F Sakurai, K Yamanishi, T Hayakawa and H Mizuguchi. (2009). Efficient adipocyte and osteoblast differentiation from mouse induced pluripotent stem cells by adenoviral transduction. Stem Cells 27:1802-1811.
11. Li F, S Bronson and C Niyibizi. (2010). Derivation of murine induced pluripotent stem cells (iPS) and assessment of their differentiation toward osteogenic lineage. J Cell Biochem 109:643-652.
12. Li F and C Niyibizi. (2012). Cells derived from murine induced pluripotent stem cells (iPSC) by treatment with members of TGF-beta family give rise to osteoblasts differentiation and form bone in vivo. BMC Cell Biol 13:35.
13. Okamoto H, Y Matsumi, Y Hoshikawa, K Takubo, K Ryoke and G Shiota. (2012). Involvement of microRNAs in regulation of osteoblastic differentiation in mouse induced pluripotent stem cells. PLoS One 7:e43800.
14. Kao CL, LK Tai, SH Chiou, YJ Chen, KH Lee, SJ Chou, YL Chang, CM Chang, SJ Chen, HH Ku and HY Li. (2010). Resveratrol promotes osteogenic differentiation and protects against dexamethasone damage in murine induced pluripotent stem cells. Stem Cells Dev 19:247-258.
15. Bilousova G, H Jun du, KB King, S De Langhe, WS Chick, EC Torchia, KS Chow, DJ Klemm, DR Roop and SM Majka. (2011). Osteoblasts derived from induced pluripotent stem cells form calcified structures in scaffolds both in vitro and in vivo. Stem Cells 29:206-216.
16. Hayashi T, H Misawa, H Nakahara, H Noguchi, A Yoshida, N Kobayashi, M Tanaka and T Ozaki. (2012). Transplantation of osteogenically differentiated mouse iPS cells for bone repair. Cell Transplant 21:591-600.
17. Bonewald LF, SE Harris, J Rosser, MR Dallas, SL Dallas, NP Camacho, B Boyan and A Boskey. (2003). von Kossa staining alone is not sufficient to confirm that mineralization in vitro represents bone formation. Calcif Tissue Int 72:537-547.
18. Egusa H, K Okita, H Kayashima, G Yu, S Fukuyasu, M Saeki, T Matsumoto, S Yamanaka and H Yatani. (2010). Gingival fibroblasts as a promising source of induced pluripotent stem cells. PLoS One 5:e12743.
19. Egusa H, M Kobayashi, T Matsumoto, J Sasaki, S Uraguchi and H Yatani. (2013). Application of cyclic strain for accelerated skeletal myogenic differentiation of mouse bone marrow-derived mesenchymal stromal cells with cell alignment. Tissue Eng Part A 19:770-782.
20. Sasaki J, T Matsumoto, H Egusa, M Matsusaki, A Nishiguchi, T Nakano, M Akashi, S Imazato and H Yatani. (2012). In vitro reproduction of endochondral ossification using a 3D mesenchymal stem cell construct. Integr Biol 4:1207-1214.
21. Egusa H, FE Schweizer, CC Wang, Y Matsuka and I Nishimura. (2005). Neuronal differentiation of bone marrowderived stromal stem cells involves suppression of discordant phenotypes through gene silencing. J Biol Chem 280: 23691-23697.
22. Itskovitz-Eldor J, M Schuldiner, D Karsenti, A Eden, O Yanuka, M Amit, H Soreq and N Benvenisty. (2000). Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol Med 6:88-95.
23. Kawaguchi J, PJ Mee and AG Smith. (2005). Osteogenic and chondrogenic differentiation of embryonic stem cells in response to specific growth factors. Bone 36:758-769.
24. Egusa H, Y Kaneda, Y Akashi, Y Hamada, T Matsumoto, M Saeki, DK Thakor, Y Tabata, N Matsuura and H Yatani. (2009). Enhanced bone regeneration via multimodal actions of synthetic peptide SVVYGLR on osteoprogenitors and osteoclasts. Biomaterials 30:4676-4686.
25. Matsumoto M, J Miura, F Takeshige and H Yatani. (2013). Mechanical and morphological evaluation of the bonddentin interface in direct resin core build-up method. Dental Mater 29:287-293.
26. Shivali G, L Praful and G Vijay. (2012). A validated Fourier transform infrared spectroscopy method for quantification of total lactones in Inula racemosa and Andrographis paniculata. Phytochem Anal 23:171-176.
27. Sato T. (1968). A modified method for lead staining of thin sections. J Eelectron Microsc 17:158-159.
28. Kim YK, LS Gu, TE Bryan, JR Kim, L Chen, Y Liu, JC Yoon, L Breschi, DH Pashley and FR Tay. (2010). Mineralisation of reconstituted collagen using polyvinylphosphonic acid/polyacrylic acid templating matrix protein analogues in the presence of calcium, phosphate and hydroxyl ions. Biomaterials 31:6618-6627.
29. Liu Y, YK Kim, L Dai, N Li, SO Khan, DH Pashley and FR Tay. (2011). Hierarchical and non-hierarchical mineralisation of collagen. Biomaterials 32:1291-1300.
30. Schmittgen TD and KJ Livak. (2008). Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3: 1101-1108.
31. Buttery LD, S Bourne, JD Xynos, H Wood, FJ Hughes, SP Hughes, V Episkopou and JM Polak. (2001). Differentiation of osteoblasts and in vitro bone formation from murine embryonic stem cells. Tissue Eng 7:89-99.
32. Schoeters GE, L de Saint-Georges, R Van den Heuvel and O Vanderborght. (1988). Mineralization of adult mouse bone marrow in vitro. Cell Tissue Kinet 21:363-374.
33. Boskey A and N Pleshko Camacho. (2007). FT-IR imaging of native and tissue-engineered bone and cartilage. Biomaterials 28:2465-2478.
34. Kawaguchi J. (2006). Generation of osteoblasts and chondrocytes from embryonic stem cells. Methods Mol Biol 330:135-148.
35. McCulloch CA, M Strugurescu, F Hughes, AH Melcher and JE Aubin. (1991). Osteogenic progenitor cells in rat bone marrow stromal populations exhibit self-renewal in culture. Blood 77:1906-1911.
36. Jaiswal N, SE Haynesworth, AI Caplan and SP Bruder. (1997). Osteogenic differentiation of purified, cultureexpanded human mesenchymal stem cells in vitro. J Cell Biochem 64:295-312.
37. Purpura KA, JE Aubin and PW Zandstra. (2004). Sustained in vitro expansion of bone progenitors is cell density dependent. Stem Cells 22:39-50.
38. Aubin JE. (1999). Osteoprogenitor cell frequency in rat bone marrow stromal populations: role for heterotypic cellcell interactions in osteoblast differentiation. J Cell Biochem 72:396-410.
39. Brown SE, W Tong and PH Krebsbach. (2009). The derivation of mesenchymal stem cells from human embryonic stem cells. Cells Tissues Organs 189:256-260.
40. Arpornmaeklong P, SE Brown, Z Wang and PH Krebsbach. (2009). Phenotypic characterization, osteoblastic differentiation, and bone regeneration capacity of human embryonic stem cellderived mesenchymal stem cells. Stem Cells Dev 18:955-968.
41. Gentleman E, RJ Swain, ND Evans, S Boonrungsiman, G Jell, MD Ball, TA Shean, ML Oyen, A Porter and MM Stevens. (2009). Comparative materials differences revealed in engineered bone as a function of cell-specific differentiation. Nat Mater 8:763-770.
42. Komori T. (2010). Regulation of osteoblast differentiation by Runx2. Adv Exp Med Biol 658:43-49.
43. Matsubara T, K Kida, A Yamaguchi, K Hata, F Ichida, H Meguro, H Aburatani, R Nishimura and T Yoneda. (2008). BMP2 regulates Osterix through Msx2 and Runx2 during osteoblast differentiation. J Biol Chem 283:29119-29125.
44. Ryoo HM, MH Lee and YJ Kim. (2006). Critical molecular switches involved in BMP-2-induced osteogenic differentiation of mesenchymal cells. Gene 366:51-57.
45. Liu G, S Vijayakumar, L Grumolato, R Arroyave, H Qiao, G Akiri and SA Aaronson. (2009). Canonical Wnts function as potent regulators of osteogenesis by human mesenchymal stem cells. J Cell Biol 185:67-75.
46. Eiraku M, N Takata, H Ishibashi, M Kawada, E Sakakura, S Okuda, K Sekiguchi, T Adachi and Y Sasai. (2011). Selforganizing optic-cup morphogenesis in three-dimensional culture. Nature 472:51-56.
47. Suga H, T Kadoshima, M Minaguchi, M Ohgushi, M Soen, T Nakano, N Takata, T Wataya, K Muguruma, et al. (2011). Self-formation of functional adenohypophysis in three-dimensional culture. Nature 480:57-62.
48. Gothard D, SJ Roberts, KM Shakesheff and LD Buttery. (2010). Engineering embryonic stem-cell aggregation allows an enhanced osteogenic differentiation in vitro. Tissue Eng Part C Methods 16:583-595.
49. Shimko DA, CA Burks, KC Dee and EA Nauman. (2004). Comparison of in vitro mineralization by murine embryonic and adult stem cells cultured in an osteogenic medium. Tissue Eng 10:1386-1398.
50. Bigdeli N, GM de Peppo, M Lenneras, P Sjovall, A Lindahl, J Hyllner and C Karlsson. (2010). Superior osteogenic capacity of human embryonic stem cells adapted to matrixfree growth compared to human mesenchymal stem cells. Tissue Eng Part A 16:3427-3440.
51. Boonrungsiman S, E Gentleman, R Carzaniga, ND Evans, DW McComb, AE Porter and MM Stevens. (2012). The role of intracellular calcium phosphate in osteoblastmediated bone apatite formation. Proc Natl Acad Sci U S A 109:14170-14175.
52. Anderson HC. (1995). Molecular biology of matrix vesicles. Clin Orthop Relat Res 314: 266-280.
53. Jahnen-Dechent W, C Schafer, M Ketteler and MD McKee. (2008). Mineral chaperones: a role for fetuin-A and osteopontin in the inhibition and regression of pathologic calcification. J Mol Med 86:379-389.
54. Atkins GJ, PS Rowe, HP Lim, KJ Welldon, R Ormsby, AR Wijenayaka, L Zelenchuk, A Evdokiou and DM Findlay. (2011). Sclerostin is a locally acting regulator of lateosteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanism. J Bone Miner Res 26:1425-1436.
55. Schafer C, A Heiss, A Schwarz, R Westenfeld, M Ketteler, J Floege, W Muller-Esterl, T Schinke and W Jahnen-Dechent. (2003). The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 112:357-366.
56. Coen G, P Ballanti, G Silvestrini, D Mantella, M Manni, S Di Giulio, S Pisano, M Leopizzi, G Di Lullo and E Bonucci. (2009). Immunohistochemical localization and mRNA expression of matrix Gla protein and fetuin-A in bone biopsies of hemodialysis patients. Virchows Arch 454:263-271.
57. van Bezooijen RL, BA Roelen, A Visser, L van der Wee-Pals, E de Wilt, M Karperien, H Hamersma, SE Papapoulos, P ten Dijke and CW Lowik. (2004). Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist. J Exp Med 199:805-814.
58. Schinke T, C Amendt, A Trindl, O Poschke, W Muller-Esterl and W Jahnen-Dechent. (1996). The serum protein alpha2-HS glycoprotein/fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells. A possible role in mineralization and calcium homeostasis. J Biol Chem 271:20789-20796.
59. Krebsbach PH, SK Lee, Y Matsuki, CA Kozak, KM Yamada and Y Yamada. (1996). Full-length sequence, localization, and chromosomal mapping of ameloblastin. A novel tooth-specific gene. J Biol Chem 271:4431-4435.
60. Deutsch D, A Palmon, LW Fisher, N Kolodny, JD Termine and MF Young. (1991). Sequencing of bovine enamelin ("tuftelin") a novel acidic enamel protein. J Biol Chem 266:16021-16028.
61. Mao Z, B Shay, M Hekmati, E Fermon, A Taylor, L Dafni, K Heikinheimo, J Lustmann, LW Fisher, MF Young and D Deutsch. (2001). The human tuftelin gene: cloning and characterization. Gene 279:181-196.
62. Hatakeyama J, S Fukumoto, T Nakamura, N Haruyama, S Suzuki, Y Hatakeyama, L Shum, CW Gibson, Y Yamada and AB Kulkarni. (2009). Synergistic roles of amelogenin and ameloblastin. J Dent Res 88:318-322.
63. Iizuka S, Y Kudo, M Yoshida, T Tsunematsu, Y Yoshiko, T Uchida, I Ogawa, M Miyauchi and T Takata. (2011). Ameloblastin regulates osteogenic differentiation by inhibiting Src kinase via cross talk between integrin beta1 and CD63. Mol Cell Biol 31:783-792.
64. Spahr A, SP Lyngstadaas, I Slaby and G Pezeshki. (2006). Ameloblastin expression during craniofacial bone formation in rats. Eur J Oral Sci 114:504-511.
65. Yamaguchi A, T Komori and T Suda. (2000). Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1. Endocr Rev 21:393-411.
66. Cheng H, W Jiang, FM Phillips, RC Haydon, Y Peng, L Zhou, HH Luu, N An, B Breyer, et al. (2003). Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am 85-A:1544-1552.
67. Ayala-Pena VB, LA Scolaro and GE Santillan. (2013). ATP and UTP stimulate bone morphogenetic protein-2,-4 and -5 gene expression and mineralization by rat primary osteoblasts involving PI3K/AKT pathway. Exp Cell Res 319:2028-2036.
68. Wutzl A, W Brozek, I Lernbass, M Rauner, G Hofbauer, C Schopper, F Watzinger, M Peterlik and P Pietschmann. (2006). Bone morphogenetic proteins 5 and 6 stimulate osteoclast generation. J Biomed Mater Res A 77:75-83.
69. Karner E, C Unger, AJ Sloan, L Ahrlund-Richter, RV Sugars and M Wendel. (2007). Bone matrix formation in osteogenic cultures derived from human embryonic stem cells in vitro. Stem Cells Dev 16:39-52.
70. Kokabu S, L Gamer, K Cox, J Lowery, K Tsuji, R Raz, A Economides, T Katagiri and V Rosen. (2012). BMP3 suppresses osteoblast differentiation of bone marrow stromal cells via interaction with Acvr2b. Mol Endocrinol 26:87-94.
71. Eyre DR and JJ Wu. (2005). Collagen cross-links. In: Collagen. Brinckmann J, Notbohm H, Müller PK, eds. Springer, Berlin, pp 207-229.
72. Brinckmann J. (2005). Collagens at a glance. In: Collagen. Brinckmann J, Notbohm H, Müller PK, eds. Springer, Berlin, pp 1-6.
73. Egusa H, K Iida, M Kobayashi, TY Lin, M Zhu, PA Zuk, CJ Wang, DK Thakor, MH Hedrick and I Nishimura. (2007). Downregulation of extracellular matrix-related gene clusters during osteogenic differentiation of human bone marrow- and adipose tissue-derived stromal cells. Tissue Eng 13:2589-2600.
74. Sasaki J, TA Asoh, T Matsumoto, H Egusa, T Sohmura, E Alsberg, M Akashi and H Yatani. (2010). Fabrication of three-dimensional cell constructs using temperature-responsive hydrogel. Tissue Eng Part A 16:2497-2504.
75. Maherali N, R Sridharan, W Xie, J Utikal, S Eminli, K Arnold, M Stadtfeld, R Yachechko, J Tchieu, et al. (2007). Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1:55-70.
76. Anguera MC, R Sadreyev, Z Zhang, A Szanto, B Payer, SD Sheridan, S Kwok, SJ Haggarty, M Sur, et al. (2012). Molecular signatures of human induced pluripotent stem cells highlight sex differences and cancer genes. Cell Stem Cell 11:75-90.